Unstable-active formulation
Galenic strategies, antioxidants, chelators and process controls designed to protect sensitive actives throughout shelf life.

CDMO partner
Cosmetic contract manufacturing (CDMO) for aesthetic medicine: feasibility, formulation, transfer, scale-up, manufacturing and documentation support under coordinated technical ownership.
01
Etternity Dermal
Projects move through verifiable gates: requirements, prototype, product–container compatibility, scale-up, specifications, manufacturing and release.
We integrate formula, process, components, quality and documentation decisions to reduce late changes and preserve project traceability.
Specialist services
Choose the closest starting point; final scope is confirmed after reviewing formula, format, market and scale.
Galenic strategies, antioxidants, chelators and process controls designed to protect sensitive actives throughout shelf life.
Product–container stability and compatibility studies designed to anticipate interaction, migration and performance loss.
Documentation structured around the product information file, safety assessment, claims and target market.
Decision-maker question
Etternity Dermal operates with an ISO 7 classified cleanroom (Class C at rest) under ISO 14644-1, terminal HEPA H14 filtration and a staged differential-pressure cascade. The site integrates a sanitary Purified Water (PW) loop and filling capability for 2–50 ml Type I glass vials. Nitrogen inerting is assessed for sensitive formulas as part of process validation. The 1–5 ml Luer-Lock syringe platform is in development; every addition will be qualified, validated and technically accepted before it is presented as an available manufacturing capability.
Capability status: current vial and process systems remain project-dependent; the syringe platform is in development.
Etternity Dermal
The evaluator turns your answers into a technical brief for an initial fit review.